Literature DB >> 24919882

Intracisternal injection of palmitoylethanolamide inhibits the peripheral nociceptive evoked responses of dorsal horn wide dynamic range neurons.

Abimael González-Hernández1, Guadalupe Martínez-Lorenzana, Javier Rodríguez-Jiménez, Gerardo Rojas-Piloni, Miguel Condés-Lara.   

Abstract

Endogenous palmitoylethanolamide (PEA) has a key role in pain modulation. Central or peripheral PEA can reduce nociceptive behavior, but no study has yet reported a descending inhibitory effect on the neuronal nociceptive activity of Aδ- and C-fibers. This study shows that intracisternal PEA inhibits the peripheral nociceptive responses of dorsal horn wide dynamic range cells (i.e., inhibition of Aδ- and C-fibers), an effect blocked by spinal methiothepin. These results suggest that a descending analgesic mechanism mediated by the serotonergic system could be activated by central PEA.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24919882     DOI: 10.1007/s00702-014-1255-6

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  27 in total

Review 1.  The search for the palmitoylethanolamide receptor.

Authors:  Jesse LoVerme; Giovanna La Rana; Roberto Russo; Antonio Calignano; Daniele Piomelli
Journal:  Life Sci       Date:  2005-08-19       Impact factor: 5.037

2.  Misdiagnosed chronic pelvic pain: pudendal neuralgia responding to a novel use of palmitoylethanolamide.

Authors:  Rocco Salvatore Calabrò; Giuseppe Gervasi; Silvia Marino; Pasquale Natale Mondo; Placido Bramanti
Journal:  Pain Med       Date:  2010-03-22       Impact factor: 3.750

3.  Use of palmitoylethanolamide in the entrapment neuropathy of the median in the wrist.

Authors:  R Conigliaro; V Drago; P S Foster; C Schievano; V Di Marzo
Journal:  Minerva Med       Date:  2011-04       Impact factor: 4.806

Review 4.  Peripheral and central pathways in pain.

Authors:  D L Hammond; T L Yaksh
Journal:  Pharmacol Ther       Date:  1981       Impact factor: 12.310

5.  Palmitoylethanolamide in the treatment of chronic pain caused by different etiopathogenesis.

Authors:  Antonio Gatti; Marzia Lazzari; Valentina Gianfelice; Annarita Di Paolo; Elisabetta Sabato; Alessandro Fabrizio Sabato
Journal:  Pain Med       Date:  2012-07-30       Impact factor: 3.750

6.  The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain.

Authors:  S I Jaggar; F S Hasnie; S Sellaturay; A S Rice
Journal:  Pain       Date:  1998-05       Impact factor: 6.961

7.  Differential mediation of descending pain facilitation and inhibition by spinal 5HT-3 and 5HT-7 receptors.

Authors:  Ahmet Dogrul; Michael H Ossipov; Frank Porreca
Journal:  Brain Res       Date:  2009-05-08       Impact factor: 3.252

8.  The analgesic effect of N-arachidonoyl-serotonin, a FAAH inhibitor and TRPV1 receptor antagonist, associated with changes in rostral ventromedial medulla and locus coeruleus cell activity in rats.

Authors:  Vito de Novellis; Enza Palazzo; Francesca Rossi; Luciano De Petrocellis; Stefania Petrosino; Francesca Guida; Livio Luongo; Annalucia Migliozzi; Luigia Cristino; Ida Marabese; Katarzyna Starowicz; Vincenzo Di Marzo; Sabatino Maione
Journal:  Neuropharmacology       Date:  2008-06-20       Impact factor: 5.250

9.  Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide.

Authors:  Frida Loría; Stefania Petrosino; Leyre Mestre; Alessandra Spagnolo; Fernando Correa; Miriam Hernangómez; Carmen Guaza; Vincenzo Di Marzo; Fabian Docagne
Journal:  Eur J Neurosci       Date:  2008-07-24       Impact factor: 3.386

Review 10.  Endocannabinoids and related fatty acid derivatives in pain modulation.

Authors:  J Michael Walker; Jocelyn F Krey; Constance J Chu; Susan M Huang
Journal:  Chem Phys Lipids       Date:  2002-12-31       Impact factor: 3.329

View more
  3 in total

Review 1.  Palmitoylethanolamide and White Matter Lesions: Evidence for Therapeutic Implications.

Authors:  Marta Valenza; Roberta Facchinetti; Luca Steardo; Caterina Scuderi
Journal:  Biomolecules       Date:  2022-08-27

2.  The Effect of Palmitoylethanolamide on Pain Intensity, Central and Peripheral Sensitization, and Pain Modulation in Healthy Volunteers-A Randomized, Double-Blinded, Placebo-Controlled Crossover Trial.

Authors:  Kordula Lang-Illievich; Christoph Klivinyi; Gudrun Rumpold-Seitlinger; Christian Dorn; Helmar Bornemann-Cimenti
Journal:  Nutrients       Date:  2022-10-01       Impact factor: 6.706

Review 3.  Chronic Pain in Dogs and Cats: Is There Place for Dietary Intervention with Micro-Palmitoylethanolamide?

Authors:  Giorgia Della Rocca; Davide Gamba
Journal:  Animals (Basel)       Date:  2021-03-29       Impact factor: 2.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.